Pathophysiology and Management of Acute Coronary Syndromes

Published Online: Monday, March 25, 2013
Follow Pharmacy_Times:
In this podcast from the BMJ Group, Mark de Belder, MD, a consultant cardiologist, speaks to James McLenachan, MRCP, a fellow consultant cardiologist, and Keith Channon, MD, professor of cardiovascular medicine at the University of Oxford, about the pathophysiology and management of acute coronary syndromes. To listen to the podcast online, click here. To download it, click here.
Related Articles
The 2013 American College of Cardiology/American Heart Association guidelines for determining statin eligibility more accurately identify increased risk of cardiovascular events.
Studies have reported that up to half of patients discontinue prescribed therapies soon after hospital discharge.
The FDA today approved Medtronic’s recapturable and self-expanding CoreValve Evolut R System for transcatheter aortic valve replacement.
FDA officials have recommended approval for Amgen’s proposed cholesterol-lowering medication, evolocumab (Repatha).
Latest Issues
$auto_registration$